Conference
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Authors
Nash R; Hutton GJ; Racke M; Popat U; Devine SM; Georges G; Griffith L; Muraro PA; Openshaw H; Sayre P
Volume
19
Publisher
Elsevier
Publication Date
February 1, 2013
DOI
10.1016/j.bbmt.2012.11.062
Conference proceedings
Transplantation and Cellular Therapy
Issue
2
ISSN
2666-6367